Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Equatorial Guinea

Equatorial Guinea

Equatorial Guinea is expected to witness a significant growth in revenue in the Other Vaccines market, with projected figures reaching US$1.34m by 2024.
Furthermore, an annual growth rate (CAGR 2024-2029) of 9.82% is anticipated, leading to a market volume of US$2.14m by 2029.
It is worth noting that in global comparison, United States is expected to generate the highest revenue in this market, with figures estimated at US$24,730.00m in 2024.
Equatorial Guinea is experiencing an increased demand for other vaccines, driven by the government's efforts to improve healthcare infrastructure.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Equatorial Guinea is experiencing a significant growth rate, with a rising demand for vaccines in the country.

Customer preferences: Equatorial Guinea's population has become more aware of the importance of vaccination in recent years, leading to an increase in demand for vaccines. The government has also been actively promoting vaccination campaigns, which has further contributed to the growth of the Other Vaccines market.

Trends in the market: The Other Vaccines market in Equatorial Guinea is expected to grow at a steady pace in the coming years. The market is being driven by an increasing demand for vaccines, particularly among children and the elderly. The demand for vaccines has also been fuelled by the outbreak of diseases such as measles and polio in neighbouring countries.

Local special circumstances: Equatorial Guinea has a relatively small population, which has made it easier for the government to implement vaccination campaigns. The government has also been working closely with international organizations to improve the country's healthcare infrastructure, which has further contributed to the growth of the Other Vaccines market.

Underlying macroeconomic factors: Equatorial Guinea's economy has been growing steadily in recent years, which has led to an increase in disposable income among the population. This has made it easier for people to afford vaccines, which has contributed to the growth of the Other Vaccines market. Additionally, Equatorial Guinea has a relatively stable political environment, which has made it easier for businesses to operate in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.